| 7.30 a.m. |
Continental Breakfast |
| |
Registration |
| |
|
| SESSION 4: |
Patient Focused Nasal Delivery |
| |
|
| |
Sponsor: DPT Laboratories
Moderator: Wallace P. Adams, Ph.D. |
| |
|
| 8.30 a.m. |
New Approaches to Nasal Spray Evaluation: Pediatric Versus Adult Actuation Profiles and Anatomically-Based Spray Pattern Tests.
Richard N. Dalby, Ph.D.,
University of Maryland, Baltimore, MD. |
| |
|
| 9.00 a.m. |
Sinus Drug Delivery by Pulsating Aerosol: Clinical Proof of Concept Studies.
Winfried Möller, Ph.D.,
Helmoltz Zentrum München, Gauting, Germany. |
| |
|
| 9.30 a.m. |
Refreshments |
| |
|
| SESSION 5: |
Economic and Environmental Initiatives for Inhaled Products |
| |
|
| |
Sponsor: V.A.R.I.
Moderator: John N. Pritchard, Ph.D. |
| |
|
| 10.00 a.m. |
Responsible Inhaler Development in Article 5 Countries: Navigating the Scientific, Regulatory, Political and Commercial Challenges.
Ashley Woodcock, M.D.,
University of Manchester, Manchester, United Kingdom. |
| |
|
| 10.30 a.m. |
Inhaler Development in Developing Markets: Overcoming Barriers to Implementation.
David J. Howlett, B.A.,
PharmaDelivery Solutions, Grimston, United Kingdom. |
| |
|
| 10.50 a.m. |
Status, Challenges and Regulatory Strategies for Replacement of Chlorofluorocarbon Propellants in Metered Dose Inhalers in China.
Shuguang Hou, Ph.D.,
3M Drug Delivery Systems, St. Paul, MN. |
| |
|
| 11.10 a.m. |
Inhalers for the Indian Subcontinent: Therapeutic and Environmental Imperatives.
Raj B. Singh, M.D.,
Apollo Hospital, Chennai, India. |
| |
|
| 11.30 a.m. |
Panel Discussion |
| |
|
| 12.00 noon |
Lunchtime |
| |
|
11.30 a.m. -
2.30 p.m |
Scientific Poster Session & Technology Exhibition |
| |
Sponsor: ‘Our Gold Sponsors’
Moderator: Richard N. Dalby, Ph.D. |
| |
|
| SESSION 6: |
Posters on the Podium |
| |
|
| |
Sponsor: ‘Our Platinum Sponsors’
Moderator: Richard N. Dalby, Ph.D. and Joanne Peart, Ph.D. |
| |
|
| |
These five poster authors have been selected to summarize their work and answer questions during a fast-paced interactive podium session. |
| |
|
| 2.05 p.m. |
Pilot Study of Surfactant Aerosol Carriers to Promote Post-Deposition Dispersion
Tim Corcoran,
University of Pittsburgh, Pittsburgh, PA |
| |
|
| 2.15 p.m. |
Novel Cinnamic Acid-Based Dehydropolymers for Emphysema: Triple Inhibitors of Elastase, Inflammation and Oxidation
Bhawana Saluja,
Virginia Commonwealth University, Richmond, VA |
| |
|
| 2.25 p.m. |
Mandibular Advancement Achieved Through a Stepped Mouthpiece Design Can Change the Size of the Upper Airways
Kurt Nikander,
Philips Respironics, Parsippany, NJ |
| |
|
| 2.35 p.m. |
Performance of a New Single-Use Disposable Dry Powder Inhaler Prototype
Christian Friebel,
Christian Albrecht University, Kiel, Germany |
| |
|
| 2.45 p.m. |
Evaluation of the Rate and Extent of Pulmonary Absorption After Administration of Two Salmeterol HFA pMDI Formulations In Healthy Volunteers
Juliet Rebello,
Cipla, Mumbai, India |
| |
|
| 3.00 p.m. |
Refreshments |
| |
|
| SESSION 7: |
New Solutions to Manufacturing and Testing Problems |
| |
|
| |
Sponsor: Trudell Medical International
Moderator: Helmut Bender, Ph.D. |
| |
|
| 3.30 p.m. |
Expanding QbD with Probabilistic Design: Ensuring Mechanically Reliable Inhalers.
Nic Bowman, B.Sc. FIMechE.,
Pfizer, Cambridge, United Kingdom. |
| |
|
| 4.00 p.m. |
Achieving Homogeneity: Combination Product Case Studies with Raman Spectroscopy.
Brent A. Donovan, Ph.D.,
Merck Research Laboratories, Summit, NJ. |
| |
|
| 4.30 p.m. |
Cascade Impactor Calibration, Mensuration and In-Use Qualification Methods: A Practical Guide.
Jolyon P. Mitchell, Ph.D.,
Trudell Medical International, London, Canada. |
| |
|
5.00 p.m. -
7.00 p.m. |
Scientific Poster Session & Technology Exhibition |
| |
Sponsor: ‘Our Gold Sponsors’
Moderator: Richard N. Dalby, Ph.D. |
| |
|
| 7.00 p.m. - 9.00 p.m. |
AAPS Inhalation and Nasal Technology Focus Group |
| |
| |
Imaging in Pulmonary and Nasal Product Development - Not Just Pretty Pictures!
Stephen P. Newman, Ph.D.,
Scientific Consultant, Nottingham, United Kingdom. |
